Comparison between C P S Shapers IPO and Saroja Pharma IPO.
C P S Shapers IPO is a SME Fixed Price IPO proposed to list at NSE SME while Saroja Pharma IPO is a SME Fixed Price proposed to list at NSE SME.
| C P S Shapers IPO | Saroja Pharma IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Shreni Shares Ltd. | Swastika Investmart Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Shreni Shares Ltd. | Swastika Investmart Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of C P S Shapers IPO is up to ₹10.52 Cr whereas the issue size of the Saroja Pharma IPO is up to ₹8.66 Cr. The final issue price of C P S Shapers IPO is ₹185.00 per share and of Saroja Pharma IPO is ₹84.00 per share.
| C P S Shapers IPO | Saroja Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹185.00 per share | ₹84.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 1600 shares |
| Fresh Issue Size | 5,68,800 shares | 10,30,400 shares |
| Fresh Issue Size (Amount) | up to ₹10.52 Cr | up to ₹8.66 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,68,800 shares | 10,30,400 shares |
| Issue Size Total (Amount) | up to ₹10.52 Cr | up to ₹8.66 Cr |
C P S Shapers IPO opens on Aug 29, 2023, while Saroja Pharma IPO opens on Aug 31, 2023. The closing date of C P S Shapers IPO and Saroja Pharma IPO is Aug 31, 2023, and Sep 05, 2023, respectively.
| C P S Shapers IPO | Saroja Pharma IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 29, 2023 | Aug 31, 2023 |
| Issue Close | Aug 31, 2023 | Sep 05, 2023 |
| Basis Of Allotment (Tentative) | Sep 05, 2023 | Sep 08, 2023 |
| Initiation of Refunds (Tentative) | Sep 06, 2023 | Sep 11, 2023 |
| Credit of Share (Tentative) | Sep 07, 2023 | Sep 12, 2023 |
| Listing date (Tentative) | Sep 07, 2023 | Sep 13, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
C P S Shapers IPO P/E ratio is 11.28, as compared to Saroja Pharma IPO P/E ratio of 23.25.
| C P S Shapers IPO | Saroja Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.80 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.28 | 23.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹38.85 Cr. | ₹33.77 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 473 | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 28 | 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 5.96 | 2.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹16.41 | ₹3.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 140.53 | 20.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the C P S Shapers IPO Retail Individual Investors (RII) are offered 2,84,400 shares while in Saroja Pharma IPO retail investors are offered 2,84,400 shares. Qualified Institutional Buyers (QIB) are offered in C P S Shapers IPO and in Saroja Pharma IPO.
| C P S Shapers IPO | Saroja Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 31,200 shares | 54,400 shares |
| QIB | ||
| NII | 2,84,400 shares | 5,15,200 shares |
| RII | 2,84,400 shares | 5,15,200 shares |
| Employee | ||
| Others | ||
| Total | 5,68,800 shares | 10,30,400 shares |
C P S Shapers IPO subscribed 253.97x in total, whereas Saroja Pharma IPO subscribed 8.88x.
| C P S Shapers IPO | Saroja Pharma IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 198.17x | 2.90x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 301.03x | 14.83x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 253.97x | 8.88x |
